BackArrowhead Pharmaceuticals Overview

Arrowhead Pharmaceuticals Accounts Payable

Arrowhead Pharmaceuticals's accounts payable is $28M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$27.78M
↓ 15.96% YoYΔ $-5.27M vs prior year quarter

Peer average / median

Loading

Arrowhead Pharmaceuticals Accounts Payable History

Loading

Arrowhead Pharmaceuticals vs. peers: Accounts Payable Comparison

Loading

Arrowhead Pharmaceuticals Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Arrowhead Pharmaceuticals (ARWR) FAQ

As of the most recent data (June 2026), ARWR shows a accounts payable of $28M. That compares with $33M in the prior-year period — down 16.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ARWR's accounts payable is now $28M (was $33M) — a 16.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Arrowhead Pharmaceuticals is outperforming or lagging.

Tracking ARWR's accounts payable over time shows whether Arrowhead Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $28M That compares with $33M in the prior-year period — down 16.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Arrowhead Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $28M) with ownership activity and broader fundamentals.

Arrowhead Pharmaceuticals's accounts payable is $28M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.